2025-09-30T11:42:29-05:00 2024-12-31 882730877 CHERRY BEKAERT ADVISORY LLC 1707 N RANDALL ROAD STE 200 ELGIN IL 60123 990 2024-01-01 364305678 THE ALLERGISTS FOUNDATION ALLE 8474271200 85 W ALGONQUIN ROAD 550 ARLINGTON HEIGHTS IL 60005 RICHARD SLAWNY EXECUTIVE DIRECTOR 8474271200 2025-09-24 1 1 MELANIE MCPEAK P01346034 8478888600 2024 2025-03-06 01:10:19Z RICHARD SLAWNY 85 W ALGONQUIN ROAD 550 ARLINGTON HEIGHTS IL 60005 219917 0 X WWW.ACAAI.ORG X 1999 IL TO MAINTAIN THE INTEGRITY AND FUTURE OF THE SPECIALTY OF ALLERGY AND IMMUNOLOGY THROUGH THE SUPPORT OF THE HIGHEST QUALITY PROFESSIONAL TRAINING AND PATIENT ASSISTANCE PROGRAMS. 12 9 0 9 0 0 197729 177552 0 0 35492 39283 0 0 233221 216835 94987 85843 0 0 0 0 0 0 0 40766 26433 135753 112276 97468 104559 1778497 2060891 3584 531 1774913 2060360 TO MAINTAIN THE INTEGRITY AND FUTURE OF THE SPECIALTY OF ALLERGY AND IMMUNOLOGY THROUGH THE SUPPORT OF THE HIGHEST QUALITY PROFESSIONAL TRAINING AND PATIENT ASSISTANCE PROGRAMS. 0 0 88142 85843 THE FOUNDATION FUNDED SEVEN COMMUNITY GRANTS DURING 2024. 88142 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 12 9 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 1 0 0 0 IL X RICHARD RILEY 8474271200 85 W ALGONQUIN ROAD 550 ARLINGTON HEIGHTS IL 60005 MELINDA MCNEAL RATHKOPF MD MBA PRESIDENT 2.00 2.00 X X 0 0 0 JEFFREY GORDON DEMAIN MD VICE PRESIDENT 2.00 0.00 X X 0 0 0 JANNA MARIE TUCK MD SECRETARY 2.00 0.00 X X 0 0 0 MARCELLA AQUINO MD MEMBER 2.00 6.00 X 0 0 0 THERESA BINGEMANN MD MEMBER 2.00 6.00 X 0 0 0 BRIAN T KELLY MD MA MEMBER 2.00 6.00 X 0 0 0 KELLY M MAPLES MD MEMBER 2.00 8.00 X 0 0 0 GAILEN D MARSHALL JR MD PHD MEMBER 2.00 12.00 X 0 20000 0 SAM B PATEL RPH MBA MEMBER 2.00 0.00 X 0 0 0 DAVID R STUKUS MD MEMBER 2.00 12.00 X 0 18000 0 JAMES M TRACY DO MEMBER 2.00 12.00 X 0 25000 0 CHERIE Y ZACHARY MD MEMBER 2.00 12.00 X 0 0 0 RICHARD SLAWNY EXECUTIVE DIRECTOR 2.00 45.00 X 0 0 0 KATERINA BARCAL ASSOCIATE EXECUTIVE DIRECTOR 4.00 0.00 X 0 0 0 KEVIN BRAGAW CFO 2.00 30.00 X 0 0 0 TODD A MAHR MD EXECUTIVE MEDICAL DIRECTOR 2.00 20.00 X 0 100000 0 0 163000 0 0 0 0 0 0 8172 169380 177552 39397 39397 2968 3082 -114 -114 -114 216835 0 0 39283 85843 85843 250 250 14911 14911 2968 2968 2750 2299 451 5554 5554 112276 88142 24134 0 238784 308711 11103 1528610 1745785 0 6395 1778497 2060891 3584 270 0 261 3584 531 X 1671195 1955758 103718 104602 1774913 2060360 1778497 2060891 104559 180888 0 X 0 1 X 1 0 X 92979 70195 206489 197729 177552 744944 92979 70195 206489 197729 177552 744944 213664 531280 26252 31936 27754 35651 39397 160990 905934 0.58640 0.65060 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO AFFILIATE 261 261 X 444755 180888 50000 230888 213867 2968 2968 216835 159308 50000 50000 109308 2968 2968 112276 PART X, LINE 2: THE FOUNDATION HAS BEEN DETERMINED TO BE EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC") AND, ACCORDINGLY, NO PROVISION HAS BEEN MADE FOR EITHER FEDERAL OR STATE INCOME TAXES. IN ADDITION, THE FOUNDATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE ("IRS") NOT TO BE A PRIVATE FOUNDATION WITHIN THE MEANING OF SECTION 501(C)(3) OF THE IRC. THE FOUNDATION HAS EVALUATED THE TAX POSITIONS TAKEN FOR ALL OPEN TAX YEARS. CURRENTLY, THE RETURNS FOR THE PRIOR THREE FISCAL YEARS ARE OPEN AND SUBJECT TO EXAMINATION BY THE IRS AND THE DEPARTMENT OF REVENUE OF CERTAIN STATES; HOWEVER, THE FOUNDATION IS NOT CURRENTLY UNDER AUDIT, NOR HAS THE FOUNDATION BEEN CONTACTED BY THESE JURISDICTIONS. BASED ON THE EVALUATION OF THE FOUNDATION'S TAX POSITIONS, MANAGEMENT BELIEVES ALL POSITIONS WOULD BE UPHELD UNDER AN EXAMINATION; THEREFORE, NO PROVISION FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAS BEEN RECORDED FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. 1 COMMUNITY GRANT AWARD 7 85843 PART I, LINE 2: THE BOARD OF DIRECTORS REVIEWS APPLICATIONS AND SCIENTIFIC PROJECTS PROPOSED AND DETERMINES WHICH OF THESE COMPLY WITH ITS CRITERIA FOR THE AWARD. AFTER A RECIPIENT IS SELECTED, THEY MUST PROVIDE A PROGRESS REPORT. FAILURE TO SUBMIT A PROGRESS REPORT AND DEMONSTRATE CONTINUATION OF THE PROJECT MAY CAUSE THE FOUNDATION TO RESCIND THE AWARD. FORM 990, PART VI, SECTION A, LINE 3 THROUGH ITS RELATED CONTROLLING ENTITY, AMERICAN COLLEGE OF ALLERGY, ASTHMA & IMMUNOLOGY, INC. (ACAAI), THE ORGANIZATION EMPLOYS EXECUTIVE ADMINISTRATION, A MANAGEMENT FIRM, TO PROVIDE MANAGEMENT AND ADMINISTRATIVE SERVICES. RICHARD SLAWNY, EXECUTIVE DIRECTOR, IS AN EMPLOYEE OF THE MANAGEMENT FIRM AND RECEIVES A SALARY OF $203,843 ALONG WITH ADDITIONAL COMPENSATION OF $52,483 FOR HIS SERVICES TO ACAAI. KEVIN BRAGAW, CFO, IS ALSO AN EMPLOYEE OF THE MANAGEMENT FIRM AND RECEIVES A SALARY OF $106,610 ALONG WITH ADDITIONAL COMPENSATION OF $16,247 FOR HIS SERVICES TO ACAAI. ACAAI ALLOCATES A PORTION OF THESE SALARIES TO THE FOUNDATION VIA AN INTERCOMPANY MANAGEMENT FEE CHARGE WHICH, SINCE THE FEE IS RECORDED AS AN IN-KIND SERVICE, DOES NOT APPEAR ON PART VIII OR PART IX OF THE 990 BUT IS REPORTED ON SCHEDULE D, PART XI LINE 2B AND PART XII LINE 2A. FORM 990, PART VI, SECTION B, LINE 11B THE TREASURER REVIEWS FORM 990 WITH THE CFO AND AUDITORS. THE TREASURER THEN REPORTS TO THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION B, LINE 12C ALL PARTICIPANTS IN ACAAI-RELATED ACTIVITIES MUST COMPLY WITH THE ACAAI CONFLICT OF INTEREST POLICY. IN ORDER TO FACILITATE IMPLEMENTATION OF THE CONFLICT OF INTEREST POLICY, THE BOARD OF REGENTS OR ITS DESIGNEE(S) SHALL DETERMINE, BASED ON THE DISCLOSURE FORM AND OTHER RELEVANT INFORMATION, WHEN AN INDIVIDUAL ENGAGED IN, OR ABOUT TO ENGAGE IN, AN ACAAI-RELATED ACTIVITY OR OTHER MATTER UNDER CONSIDERATION HAS AN ACTUAL, POTENTIAL, OR APPARENT CONFLICT OF INTEREST REQUIRING SOME RESPONSE BY ACAAI. SPECIFICALLY, SUBJECT TO THE PROCEDURES SET FORTH HEREIN, THE BOARD OF REGENTS OR ITS DESIGNEE(S) MAY REQUIRE ANY ACTION THEY DEEM APPROPRIATE, INCLUDING, BUT NOT LIMITED TO, THE FOLLOWING: (1) DISCLOSURE OF THE INTEREST TO THE OTHER PARTICIPANTS IN THE DECISION- OR POLICY-MAKING BODY (E.G., COMMITTEE, EDITORIAL BOARD). (2) WRITTEN AND, IN SOME CASES, ORAL DISCLOSURE OF THE INTEREST (E.G., TO AN AUDIENCE RECEIVING THE RESULTS OF CLINICAL RESEARCH OR AT SCIENTIFIC OR EDUCATIONAL SESSIONS). (3) RECUSAL FROM VOTING ON A MATTER AND LIMITATION OF THE INDIVIDUAL'S PARTICIPATION ONLY TO THE PROVISION OF FACTUAL INFORMATION OF BENEFIT TO THE GROUP DISCUSSION. (4) COMPLETE RECUSAL FROM A PORTION OF A MEETING OR FROM OTHER CONSIDERATION OF THE SUBJECT MATTER. (5) REPLACEMENT OF THE INDIVIDUAL IN THE AFFECTED POSITION OR ACTIVITY. IN MOST INSTANCES, DISCLOSURE OF CONFLICTING OR POTENTIALLY CONFLICTING INTERESTS WILL SUFFICE TO PROTECT ACAAI'S INTERESTS. IN OTHER WORDS, ONCE SUCH A CONFLICT IS FULLY DISCLOSED TO THE RELEVANT PARTIES, THE BOARD GENERALLY WILL BE ABLE TO EVALUATE THE POSSIBLE INFLUENCE OF THE DISCLOSED INTEREST. HOWEVER, IN OTHER SITUATIONS, DISCLOSURE ALONE IS NOT DEEMED TO BE SUFFICIENT. IN SITUATIONS WHERE DISCLOSURE DOES NOT ADEQUATELY DEAL WITH ACTUAL OR POTENTIAL PROBLEMS, ADDITIONAL ACTION, INCLUDING DENIAL OF PARTICIPATION IN THE AFFECTED ACTIVITY OR CONSIDERATION OF THE MATTER, MAY BE NECESSARY. IN ALL SUCH SITUATIONS, THE BOARD OF REGENTS OR ITS DESIGNEE(S) WILL WEIGH ALL THE FACTS AND CIRCUMSTANCES AND DETERMINE WHAT IS IN THE BEST INTERESTS OF ACAAI. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES THESE DOCUMENTS AVAILABLE TO THE PUBLIC UPON SPECIFIC REQUEST. AMERICAN COLLEGE OF ALLERGY ASTHMA & IMMUNOLOGY 85 W ALGONQUIN ROAD ARLINGTON HEIGHTS IL 60005 840457367 CHARITABLE IL 501(C)(3) LINE 10 N/A 0 JOINT COUNCIL OF ALLERGY ASTHMA & IMMUNOLOGY 85 W ALGONQUIN ROAD ARLINGTON HEIGHTS IL 60005 510163641 CHARITABLE IL 501(C)(6) AMERICAN COLLEGE OF ALLERGY ASTHMA & IMMUNOLOGY 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0